Table 2.
Drug | Package size | ISKRAa | Min No. of Packages | Extra units | IDSAb | Min No. of Packages | Extra units | NICEc | Min No. of Packages | Extra units |
---|---|---|---|---|---|---|---|---|---|---|
Clarithromycin | 14x250 mgd | 2x250 mg, 10 days | 2 | 8 | 2x250 mg, 10 days | 2 | 8 | 2x250-500 mg, 5 days | 1 | 4 |
5x500 mg | 2x250 mg, 10 days | n/a | 2x250 mg, 10 days | n/a | 2x250-500 mg, 5 days | 2 | 0 | |||
7x500 mgd | 2x250 mg, 10 days | n/a | 2x250 mg, 10 days | n/a | 2x250-500 mg, 5 days | 2 | 4 | |||
14x500 mgd | 2x250 mg, 10 days | n/a | 2x250 mg, 10 days | n/a | 2x250-500 mg, 5 days | 1 | 4 | |||
Penicillin V | 30x1000000 IUd | 3x1 500 000 IU, 10 days | 2 | 15 | 4x250 mg, 10 days | n/a | 4x500 mg, 5-10 days | n/a | ||
2x500 mg, 10 days | 2x1000 mg, 5-10 days | |||||||||
30x1500000 IUd | 3x1 500 000 IU, 10 days | 1 | 0 | 4x250 mg, 10 days | n/a | 4x500 mg, 5-10 days | n/a | |||
2x500 mg, 10 days | 2x1000 mg, 5-10 days | |||||||||
Erythromycin | 16x250 mgd | n/a | n/a | 4x250-500 mg, 5 days | 3 | 8 | ||||
2x500-1000 mg, 5 days | 3 | 8 |
n/a – not applicable; IU-international unit; extra units of drugs are presented with reference to the original formulation
aThe Intersectoral Society for Antibiotic Resistance Control (ISKRA) guidelines on sore throat: diagnostic and therapeutic approach – Croatian national guidelines
bClinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America
cNational Institute for Health and Care Excellence (NICE) Sore throat (acute): antimicrobial prescribing
dincluded in Croatian national reimbursement lists on 1st of August 2018